Headache News

AUSTIN, Texas — Sustained freedom from pain and the most bothersome migraine symptom was achieved in more patients treated with investigational STS 101 compared with placebo, according to a study presented here.

AUSTIN, Texas — Atogepant significantly improved daily functioning and reduced physical impairment in adults with chronic migraine within 1 week of treatment, according to study results presented here by Jessica Ailani, MD.

AUSTIN, Texas — In-clinic administration of IV ketamine significantly improved refractory chronic migraine pain intensity in a small cohort of patients, according to a poster presented here.

AUSTIN, Texas — The use of remote electrical neuromodulation in adolescents with acute migraine was safe and efficacious as a nonpharmacological treatment option, according to a poster presented here.

AUSTIN, Texas — Significant improvement was reported in children who have follow-up visits to a headache clinic, although Black patients and patients on Medicaid were less likely to complete these visits, according to data presented here.

AUSTIN, Texas — A combination of THC and CBD administered via vaporization was beneficial in migraine treatment, relieving pain and patients’ most bothersome symptoms, according to a study presented here.

AUSTIN, Texas — Hispanic patients with headache disorders were overall satisfied with telemedicine services, regardless of English language proficiency, according to a poster presented here.

AUSTIN, Texas — Specialty office visits for chronic migraine were significantly reduced in individuals who participated in a group telemedicine program, according to research presented at the American Headache Society’s annual meeting.

I want to reflect on a recent patient I admitted: a woman in her 40s who presented with an intractable headache.

The FDA has accepted for review a 505(b)(2) new drug application for STS101, a novel, investigational nasal powder for the acute treatment of migraine.